Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

A novel AI laboratory platform to identify bacteria and AMR data challenge

Domaine:

healthcare
Créateur:
Har
Éditeur:
Viv
Hôte:avatar
Antimicrobial resistance (AMR) is considered a global public health threat by several health-focused, research organizations and academic institutions including the World Health Organization and similar sister organization like the Food and Agriculture Organization of the United Nation. For a very long time, Hospital AMR surveillance is regarded as an essential strategy to identify resistant bacteria, their spread and prevalence. On the contrary, this strategy of AMR surveillance developed around culture-based isolation of bacteria from hospital patients, and their phenotypic response to a battery of antibiotics has been shown to be less representative and time-consuming. These time-consuming techniques coupled with poor laboratory information management systems seen within several clinical and research laboratories in Ghana and several resource limited environments have contributed to the lack of data on pathogens of public health importance and their epidemiology. Wastewater-based surveillance is increasingly being recognized as an important approach to monitoring population-level AMR. Therefore, we hypothesized and proposed a pilot project to decipher the nexus of AMR distribution using digital innovation and molecular detection using wastewater samples in Ghana. From the results of this pilot using 171 wastewater samples, we identified 45% (77/171) E. coli contaminated wastewater with 62% of them showing ESBL resistance. As part of this data challenge we propose to answer the following questions; 1) whether or not we can compare results from our pilot study to extended hospital and community based surveillance datasets from big pharma. 2) Understand AMR trends for E. coli, its associated mechanisms comparing our genotype data to those collected in the data challenge database we requesting. 3) Validate our AMR detection and bacteria identification platform using the requested database.

Visit

doi.orgsearchamr.vivli.org

Tags

Antimicrobial Resistance

Similaires

Data Challenge: PREDICT-AMRAMR Sentinel — Vivli 2026 AMR Data Challenge Pre-RegistrationData Challenge: TOWARDS INCLUSIVE AMR PREDICTIONData Challenge: Predicting AMR gene determinants and phenotypesAMR ChallengeAMR VIVLI Multi-Region Data Challenge Project

Data Challenge: PREDICT-AMR

Antimicrobial resistance (AMR) is one of the top 10 global health threats, and antimicrobial-resista

AMR Sentinel — Vivli 2026 AMR Data Challenge Pre-Registration

Pre-registered secondary analysis linking Vivli AMR Surveillance Register (SPIDAAR, ATLAS, SMART) wi

Data Challenge: TOWARDS INCLUSIVE AMR PREDICTION

Antimicrobial resistance surveillance remains blind to persons with disabilities (PWDs) — a populati

Data Challenge: Predicting AMR gene determinants and phenotypes

Traditional methods like antimicrobial susceptibility testing (AST), mainly used for antimicrobial r

AMR Challenge

Antimicrobial resistance is a global problem that has so far resisted modern therapeutic interventio

AMR VIVLI Multi-Region Data Challenge Project

Expression of Interest Summary: Leveraging ATLAS Data to Address AMR in S.Pneumoniae and S.Aureus O